User: Guest  Login
Document type:
journal article 
Author(s):
Reck, M; von Pawel, J; Macha, HN; Kaukel, E; Deppermann, KM; Bonnet, R; Ulm, K; Hessler, S; Gatzemeier, U 
Title:
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. 
Abstract:
BACKGROUND: Paclitaxel administered in combination with a topoisomerase-II inhibitor (such as etoposide) and carboplatin is an effective and safe first-line treatment for patients with small-cell lung cancer (SCLC). We conducted a randomized phase III multicenter trial to determine whether paclitaxel plus etoposide plus carboplatin improves the outcome of patients with primary SCLC relative to standard chemotherapy (carboplatin, etoposide, and vincristine). METHODS: Between January 1998 and Dece...    »
 
Journal title abbreviation:
J Natl Cancer Inst 
Year:
2003 
Journal volume:
95 
Journal issue:
15 
Pages contribution:
1118-27 
Language:
eng 
Print-ISSN:
0027-8874 
TUM Institution:
Institut für Medizinische Statistik und Epidemiologie